178 related articles for article (PubMed ID: 27812034)
21. Large animal models for foamy virus vector gene therapy.
Trobridge GD; Horn PA; Beard BC; Kiem HP
Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
[TBL] [Abstract][Full Text] [Related]
22. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
23. Foamy virus vectors.
Russell DW; Miller AD
J Virol; 1996 Jan; 70(1):217-22. PubMed ID: 8523528
[TBL] [Abstract][Full Text] [Related]
24. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
[TBL] [Abstract][Full Text] [Related]
25. Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.
Olszko ME; Adair JE; Linde I; Rae DT; Trobridge P; Hocum JD; Rawlings DJ; Kiem HP; Trobridge GD
Gene Ther; 2015 Jul; 22(7):591-5. PubMed ID: 25786870
[TBL] [Abstract][Full Text] [Related]
26. Nonintegrating foamy virus vectors.
Deyle DR; Li Y; Olson EM; Russell DW
J Virol; 2010 Sep; 84(18):9341-9. PubMed ID: 20592072
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
[TBL] [Abstract][Full Text] [Related]
28. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
29. Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy.
El Ashkar S; Van Looveren D; Schenk F; Vranckx LS; Demeulemeester J; De Rijck J; Debyser Z; Modlich U; Gijsbers R
Mol Ther Nucleic Acids; 2017 Jun; 7():231-245. PubMed ID: 28624199
[TBL] [Abstract][Full Text] [Related]
30. Feline foamy virus-based vectors: advantages of an authentic animal model.
Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
[TBL] [Abstract][Full Text] [Related]
31. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins.
Bastone P; Bravo IG; Löchelt M
Virology; 2006 Apr; 348(1):190-9. PubMed ID: 16443252
[TBL] [Abstract][Full Text] [Related]
32. Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.
Nalla AK; Trobridge GD
Biomedicines; 2016 Mar; 4(2):. PubMed ID: 28536375
[TBL] [Abstract][Full Text] [Related]
33. Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.
Heinkelein M; Hoffmann U; Lücke M; Imrich H; Müller JG; Meixensberger J; Westphahl M; Kretschmer A; Rethwilm A
Cancer Gene Ther; 2005 Dec; 12(12):947-53. PubMed ID: 15905857
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle dependence of foamy virus vectors.
Patton GS; Erlwein O; McClure MO
J Gen Virol; 2004 Oct; 85(Pt 10):2925-2930. PubMed ID: 15448354
[TBL] [Abstract][Full Text] [Related]
35. In-Vivo Gene Therapy with Foamy Virus Vectors.
Rajawat YS; Humbert O; Kiem HP
Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors.
Heinkelein M; Schmidt M; Fischer N; Moebes A; Lindemann D; Enssle J; Rethwilm A
J Virol; 1998 Aug; 72(8):6307-14. PubMed ID: 9658069
[TBL] [Abstract][Full Text] [Related]
37. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
38. Transduction of human embryonic stem cells by foamy virus vectors.
Gharwan H; Hirata RK; Wang P; Richard RE; Wang L; Olson E; Allen J; Ware CB; Russell DW
Mol Ther; 2007 Oct; 15(10):1827-33. PubMed ID: 17622243
[TBL] [Abstract][Full Text] [Related]
39. Lentivirus and foamy virus vectors: novel gene therapy tools.
Pandya S; Klimatcheva E; Planelles V
Expert Opin Biol Ther; 2001 Jan; 1(1):17-40. PubMed ID: 11727544
[TBL] [Abstract][Full Text] [Related]
40. Gene transfer using replication-defective human foamy virus vectors.
Bieniasz PD; Erlwein O; Aguzzi A; Rethwilm A; McClure MO
Virology; 1997 Aug; 235(1):65-72. PubMed ID: 9300037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
